Compare EQH & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | DVA |
|---|---|---|
| Founded | 1859 | 1994 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Specialty Insurers | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.1B |
| IPO Year | N/A | 2002 |
| Metric | EQH | DVA |
|---|---|---|
| Price | $38.18 | $151.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | $60.80 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 2.8M | 829.4K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 9.84 |
| Revenue | N/A | ★ $13,643,069,000.00 |
| Revenue This Year | $43.41 | $3.80 |
| Revenue Next Year | $7.61 | $3.04 |
| P/E Ratio | ★ N/A | $15.35 |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $37.51 | $101.00 |
| 52 Week High | $56.61 | $159.42 |
| Indicator | EQH | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 30.88 | 62.13 |
| Support Level | N/A | $146.00 |
| Resistance Level | $55.05 | $159.42 |
| Average True Range (ATR) | 1.69 | 4.29 |
| MACD | -0.28 | -1.24 |
| Stochastic Oscillator | 7.65 | 44.11 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.